SCYX
Scynexis IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$74.22M
P/E Ratio
—
EPS
$-0.17
Beta
1.15
52W High
$1.31
52W Low
$0.56
50-Day MA
$0.90
200-Day MA
$0.79
Dividend Yield
—
Profit Margin
-41.80%
Forward P/E
3.72
PEG Ratio
0.00
About Scynexis Inc
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
Fundamentals
| Revenue (TTM) | $20.60M |
| Gross Profit (TTM) | $20.60M |
| EBITDA | $-36.54M |
| Operating Margin | 56.40% |
| Return on Equity | -16.50% |
| Return on Assets | -13.40% |
| Revenue/Share (TTM) | $0.41 |
| Book Value | $1.13 |
| Price-to-Book | 1.51 |
| Price-to-Sales (TTM) | 3.60 |
| EV/Revenue | 1.782 |
| EV/EBITDA | 0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1809.00% |
| Shares Outstanding | $79.44M |
| Float | $32.38M |
| % Insiders | 1.96% |
| % Institutions | 25.25% |
Historical Volatility
HV 10-Day
53.32%
HV 20-Day
58.74%
HV 30-Day
72.26%
HV 60-Day
70.20%
HV Rank
57.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.47 target)
1
Strong Buy2
BuyData last updated: 4/30/2026